Cardiff Oncology (CRDF) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Cardiff Oncology (CRDF) over the last 16 years, with Q3 2025 value amounting to $254000.0.
- Cardiff Oncology's Receivables - Net fell 5889.97% to $254000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $254000.0, marking a year-over-year decrease of 5889.97%. This contributed to the annual value of $773000.0 for FY2024, which is 16840.28% up from last year.
- Latest data reveals that Cardiff Oncology reported Receivables - Net of $254000.0 as of Q3 2025, which was down 5889.97% from $526000.0 recorded in Q2 2025.
- Cardiff Oncology's 5-year Receivables - Net high stood at $773000.0 for Q4 2024, and its period low was $161000.0 during Q2 2023.
- Its 5-year average for Receivables - Net is $454842.1, with a median of $447000.0 in 2022.
- Its Receivables - Net has fluctuated over the past 5 years, first crashed by 7078.04% in 2023, then soared by 21212.12% in 2024.
- Quarter analysis of 5 years shows Cardiff Oncology's Receivables - Net stood at $535000.0 in 2021, then skyrocketed by 44.11% to $771000.0 in 2022, then tumbled by 62.65% to $288000.0 in 2023, then surged by 168.4% to $773000.0 in 2024, then crashed by 67.14% to $254000.0 in 2025.
- Its last three reported values are $254000.0 in Q3 2025, $526000.0 for Q2 2025, and $405000.0 during Q1 2025.